L J Schouten

Author PubWeight™ 53.06‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet 1994 4.38
2 Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 2000 2.97
3 Development of a record linkage protocol for use in the Dutch Cancer Registry for Epidemiological Research. Int J Epidemiol 1990 2.69
4 A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol 1999 2.36
5 Prognostic significance of radial margins of clearance in rectal cancer. Br J Surg 1996 2.15
6 Age-specific differences in the diagnostics and treatment of cancer patients aged 50 years and older in the province of Limburg, The Netherlands. Ann Oncol 1996 1.76
7 The joint association of air pollution and noise from road traffic with cardiovascular mortality in a cohort study. Occup Environ Med 2008 1.63
8 Red and processed meat consumption and the risk of esophageal and gastric cancer subtypes in The Netherlands Cohort Study. Ann Oncol 2012 1.49
9 Cancer mortality trends in the EU and acceding countries up to 2015. Ann Oncol 2003 1.38
10 Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study. Gut 2010 1.38
11 Rising trends in the incidence of and mortality from cutaneous melanoma in the Netherlands: a Northwest to Southeast gradient? Eur J Cancer 2003 1.32
12 Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort. Gut 2005 1.26
13 Cancer incidence in The Netherlands in 1989 and 1990: first results of the nationwide Netherlands cancer registry. Coordinating Committee for Regional Cancer Registries. Eur J Cancer 1995 1.12
14 Cancer in the very elderly Dutch population. Cancer 2000 1.12
15 Age-specific differences in treatment and survival of patients with cervical cancer in the southeast of The Netherlands, 1986-1996. Eur J Cancer 2002 1.06
16 Reproductive and hormonal factors in association with ovarian cancer in the Netherlands cohort study. Am J Epidemiol 2010 0.99
17 Alcohol intake and ovarian cancer risk: a pooled analysis of 10 cohort studies. Br J Cancer 2006 0.95
18 Influence of age, comorbidity and performance status on the choice of treatment for patients with non-small cell lung cancer; results of a population-based study. Lung Cancer 2004 0.95
19 Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10 years after diagnosis. Gut 2006 0.95
20 A novel classification of colorectal tumors based on microsatellite instability, the CpG island methylator phenotype and chromosomal instability: implications for prognosis. Ann Oncol 2013 0.93
21 The etiology of uterine sarcomas: a pooled analysis of the epidemiology of endometrial cancer consortium. Br J Cancer 2013 0.93
22 Dairy consumption and ovarian cancer risk in the Netherlands Cohort Study on Diet and Cancer. Br J Cancer 2006 0.92
23 Genetic susceptibility to sporadic ovarian cancer: a systematic review. Biochim Biophys Acta 2011 0.91
24 Tea and coffee drinking and ovarian cancer risk: results from the Netherlands Cohort Study and a meta-analysis. Br J Cancer 2007 0.91
25 Cigarette smoking, von Hippel-Lindau gene mutations and sporadic renal cell carcinoma. Br J Cancer 2006 0.87
26 A blind review and an informed review of interval breast cancer cases in the Limburg screening programme, the Netherlands. J Med Screen 2000 0.86
27 Loco-regional recurrences after mastectomy in breast cancer: prognostic factors and implications for postoperative irradiation. Radiother Oncol 1999 0.84
28 The Neuro-Oncology Register. Neuroepidemiology 1992 0.84
29 False-negative findings in skin cancer and melanoma screening. J Am Acad Dermatol 1995 0.83
30 [Alterations of stage distribution for breast cancer since the implementation of national screening program in the Netherlands during 1989-1995]. Ned Tijdschr Geneeskd 2000 0.83
31 Factors influencing participation among melanoma screening attenders. Acta Derm Venereol 1997 0.82
32 Adjuvant chemo-hormonal therapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) with or without medroxyprogesterone acetate (MPA) for node-positive cancer patients, update at 12 years follow up. Breast 2001 0.82
33 Mammography in the follow-up after breast-conserving treatment in cancer of the breast: suitability for mammographic interpretation, validity and interobserver variation. Br J Radiol 1995 0.81
34 Hormone replacement therapy and high incidence of breast cancer between mammographic screens. Lancet 1997 0.80
35 Diabetes type II, other medical conditions and pancreatic cancer risk: a prospective study in The Netherlands. Br J Cancer 2013 0.80
36 Validation of a database on acrylamide for use in epidemiological studies. Eur J Clin Nutr 2010 0.79
37 Incidence of primary central nervous system cancers in South and East Netherlands in 1989-1994. Neuroepidemiology 1998 0.79
38 Skin cancer screening focusing on melanoma yields more selective attendance. Arch Dermatol 1995 0.79
39 The prognostic significance of steroid receptor activity in tumor tissues of patients with primary breast cancer. Am J Clin Oncol 1997 0.78
40 Risk factors, genetic predisposition and mutations in the VHL gene in sporadic renal cell carcinoma: The Netherlands Cohort Study. IARC Sci Publ 2002 0.78
41 Anti-apoptotic phenotype is associated with decreased locoregional recurrence rate in breast cancer. Anticancer Res 2000 0.76
42 [Increasing incidence of mesothelioma in the future due to occupational exposure to asbestos in the past]. Ned Tijdschr Geneeskd 1997 0.75
43 Ascertainment corrected rates. Int J Epidemiol 1994 0.75
44 A plea for better coding rules for bladder cancer. Br J Cancer 1993 0.75
45 [Incidence and treatment of prostatic carcinoma in the region of the Amsterdam Comprehensive Cancer Center, 1989-1994]. Ned Tijdschr Geneeskd 1997 0.75
46 [Doctors are increasingly held liable for missed diagnosis of cancer in mass screening]. Ned Tijdschr Geneeskd 2001 0.75
47 Incidence of primary cancer of the central nervous system in southeastern Netherlands during the period 1980-94. Specialists in neuro-oncology in southeastern Netherlands. Cancer Causes Control 1998 0.75
48 A phase II study with mitomycin and vindesine in metastatic pretreated breast cancer. Eur J Cancer 1991 0.75
49 Prostate cancer susceptibility genes on 8p21-23 in a Dutch population. Prostate Cancer Prostatic Dis 2013 0.75
50 Ploidy and S-phase fractions (SPF) of primary breast cancers and their nodal metastases. Breast Cancer Res Treat 1994 0.75
51 [Socioeconomic variations in the survival of cancer patients]. Ned Tijdschr Geneeskd 1996 0.75
52 Remarkable age-dependent sex differences in the incidence of adenocarcinoma of the gastric cardia and oesophagus in The Netherlands. Eur J Cancer 1997 0.75
53 Total skin examination during screening for malignant melanoma does not increase the detection rate. Br J Dermatol 1996 0.75
54 Volunteer melanoma screenings. Follow-up, compliance, and outcome. Dermatol Surg 1997 0.75
55 A uniform histological cluster scheme for ICD-O-coded primary central nervous system tumors. Neuroepidemiology 1998 0.75